FUSAR POLI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 16.312
AS - Asia 11.505
EU - Europa 7.551
SA - Sud America 2.189
AF - Africa 500
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 11
Totale 38.099
Nazione #
US - Stati Uniti d'America 15.860
SG - Singapore 3.317
CN - Cina 3.214
HK - Hong Kong 2.160
IE - Irlanda 2.000
BR - Brasile 1.651
IT - Italia 1.300
VN - Vietnam 1.257
RU - Federazione Russa 1.004
DE - Germania 731
FR - Francia 641
FI - Finlandia 469
GB - Regno Unito 382
IN - India 337
SE - Svezia 247
CA - Canada 224
UA - Ucraina 221
ZA - Sudafrica 214
BD - Bangladesh 179
AR - Argentina 173
MX - Messico 153
NL - Olanda 151
IQ - Iraq 133
JP - Giappone 125
TR - Turchia 100
CO - Colombia 97
ID - Indonesia 90
EC - Ecuador 88
ES - Italia 84
PK - Pakistan 74
PL - Polonia 66
MA - Marocco 62
PH - Filippine 61
AT - Austria 60
SA - Arabia Saudita 56
MY - Malesia 50
VE - Venezuela 48
CL - Cile 44
UZ - Uzbekistan 43
TN - Tunisia 38
AE - Emirati Arabi Uniti 37
TH - Thailandia 34
BE - Belgio 32
MU - Mauritius 31
PE - Perù 30
PY - Paraguay 30
JO - Giordania 28
KE - Kenya 28
LT - Lituania 28
KR - Corea 26
NP - Nepal 25
AU - Australia 23
DZ - Algeria 22
EG - Egitto 22
ET - Etiopia 22
AZ - Azerbaigian 20
CH - Svizzera 20
IL - Israele 18
CZ - Repubblica Ceca 17
AL - Albania 16
IR - Iran 16
JM - Giamaica 16
PA - Panama 13
PT - Portogallo 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
OM - Oman 12
UY - Uruguay 12
KZ - Kazakistan 11
ZM - Zambia 11
BG - Bulgaria 9
PS - Palestinian Territory 9
BY - Bielorussia 8
LB - Libano 8
RO - Romania 8
RS - Serbia 8
SN - Senegal 8
CR - Costa Rica 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
AO - Angola 6
BH - Bahrain 6
CI - Costa d'Avorio 6
EU - Europa 6
GA - Gabon 6
LV - Lettonia 6
HN - Honduras 5
NG - Nigeria 5
NI - Nicaragua 5
QA - Qatar 5
AM - Armenia 4
DK - Danimarca 4
GE - Georgia 4
GR - Grecia 4
KW - Kuwait 4
MM - Myanmar 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
Totale 38.015
Città #
Dallas 3.726
Hong Kong 2.116
Dublin 1.951
San Jose 1.684
Singapore 1.645
Chandler 1.614
Ashburn 1.490
Beijing 833
Boardman 584
Lauterbourg 529
Milan 516
Ho Chi Minh City 453
Princeton 438
Lawrence 430
Los Angeles 421
Hanoi 304
Wilmington 300
Helsinki 282
Medford 273
Redondo Beach 271
Jacksonville 260
Nanjing 248
Buffalo 212
Munich 209
New York 178
Johannesburg 159
Moscow 145
Shanghai 140
São Paulo 140
Tokyo 105
Toronto 104
Nanchang 101
Santa Clara 87
Ann Arbor 85
Orem 85
The Dalles 84
Chicago 81
Seattle 79
Council Bluffs 78
Shenyang 73
Turku 73
Falkenstein 72
Nuremberg 71
Changsha 69
Montreal 67
Norwalk 67
Frankfurt am Main 65
Guangzhou 65
Hebei 64
Washington 64
Mexico City 60
Pavia 60
Zibido San Giacomo 60
Warsaw 58
Brooklyn 57
Da Nang 55
Rio de Janeiro 55
Chennai 52
Groningen 52
Haiphong 51
London 50
Rome 50
Tianjin 49
Baghdad 47
Amsterdam 46
Hangzhou 46
San Francisco 45
Stockholm 45
Pune 44
Columbus 42
Woodbridge 42
Jiaxing 41
Houston 40
Tashkent 40
Phoenix 39
Atlanta 37
Fairfield 37
Belo Horizonte 36
Denver 35
Las Vegas 35
Quito 35
Hyderabad 34
Medellín 33
Brasília 31
Jakarta 31
Boston 30
Des Moines 30
Biên Hòa 28
Dhaka 28
Lahore 28
Turin 28
Brussels 27
Curitiba 27
Hải Dương 27
Bangkok 26
Shijiazhuang 26
Campinas 25
Cascina 25
Zhengzhou 25
Manchester 24
Totale 25.164
Nome #
Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment 780
Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis 497
Therapist's Assessment of Their Patient's Session‐Level Emotional Processes: Validation of the In‐Session Patient Affective Reactions Questionnaire–Clinician Form 469
Reporting and Representation of Race and Ethnicity in Clinical Trials of Pharmacotherapy for Mental Disorders 456
Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosis 449
Local adaptation and validation of a transdiagnostic risk calculator for first episode psychosis using mental health patient records 441
Peripheral inflammation and neurocognitive functioning in early psychosis: Specific associations of TNF-α and IL-6 with social cognition 336
A Case of a College Student Presenting with Mild Mental Health Problems 308
Method-specific suicide mortality rates among older adults in 47 countries and territories, 1996–2021, with projections to 2050: a global time series and modelling study 288
A Pilot Study on Covid and Autism: Prevalence, Clinical Presentation and Vaccine Side Effects 152
Laterality effect on emotional faces processing: ALE meta-analysis of evidence 151
Targeting the effects of omega-3 and omega-6 fatty acid supplementation on schizophrenic spectrum disorders: Role of neuroimaging 143
Anti-depressive therapies after heart transplantation 141
Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries 140
Can acute tryptophan depletion modulate brain function in absence of behavioural effects? 137
Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent? 131
Paul Eugen Bleuler and the birth of schizophrenia (1908) 131
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies 128
Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis 127
Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders 123
The lived experience of mental disorders in adolescents: a bottom‐up review co‐designed, co‐conducted and co‐written by experts by experience and academics 122
Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis 122
A general approach for combining voxel-based meta-analyses conducted in different neuroimaging modalities 120
Acute oxytocin effects in inferring others’ beliefs and social emotions in people at clinical high risk for psychosis 120
Marfan syndrome and liability to psychosis 119
Second Life virtual world: A heaven for autistic people? 117
Depression and quality of life in patients living 10 to 18 years beyond heart transplantation 116
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis 115
Neurofunctional maps of the 'maternal brain' and the effects of oxytocin: a multimodal voxel-based meta-analysis. 115
Developing and Validating an Individualized Clinical Prediction Model to Forecast Psychotic Recurrence in Acute and Transient Psychotic Disorders: Electronic Health Record Cohort Study 115
Socioeconomic provisions for specialist training in Italy and the UK: integrating the differences 114
Understanding Source Monitoring subtypes and their relation to psychosis: a systematic review and meta-analysis 113
Depression after lung transplantation: causes and treatment 111
A large scale meta-analytic atlas of mental health problems prevalence during the COVID-19 early pandemic 111
Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders 110
Medicine and the arts. Two allegories of love by Agnolo di Cosimo di Mariano Bronzino and Bartels, et al 109
Uncovering the neural correlates of the ketogenic diet: the contribution of functional neuroimaging 109
Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013 109
Clinical-learning versus machine-learning for transdiagnostic prediction of psychosis onset in individuals at-risk 109
EFFECTS OF INTRANASAL OXYTOCIN ON RESTING CEREBRAL BLOOD FLOW IN PEOPLE AT ULTRA-HIGH RISK FOR PSYCHOSIS 108
Diagnostic and prognostic significance of brief limited intermittent psychotic symptoms (BLIPS) in individuals at ultra high risk 108
Memantine as a neuroprotective agent in early stages of psychosis 107
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis 107
Determinants of quality of life in Marfan syndrome 106
Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis 106
Prevalence of self-reported childhood abuse in psychosis: A meta-analysis of retrospective studies 106
Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis 106
The dark side of the moon: meta-analytical impact of recruitment strategies on risk enrichment in the clinical high risk state for psychosis 106
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies 106
Semistructured Interview for Bipolar At Risk States (SIBARS) 105
World/self ambivalence: A shared mechanism in different subsets of psychotic experiences? Linking symptoms with resting-state fMRI 105
A systematic review and meta-analysis of mental health service use in people who report psychotic experiences 104
Identifying children and adolescents at ultra high risk of psychosis in Italian neuropsychiatry services: a feasibility study 103
Altering the course of schizophrenia: Progress and perspectives 102
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 102
Perceived Family Functioning Profile in Adolescents at Clinical High Risk for Psychosis: Rigidity as a Possible Preventive Target 101
A systematic review and synthesis of 489 studies investigating treatments for negative symptoms in the schizophrenia spectrum: Trial designs, demographics and clinical characteristics 100
Ten years of extended life: Quality of life among heart transplantation survivors 100
Heterogeneity of psychosis risk within individuals at clinical high risk: A meta-analytical stratification 100
Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state 100
Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis 100
Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis 99
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis 99
Getting old with a new heart: impact of age on depression and quality of life in long-term heart transplant recipients 98
Outreach and support in South-London (OASIS) 2001—2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis 98
Integrating the negative psychotic symptoms in the high risk criteria for the prediction of psychosis 96
Lifestyles and cardiovascular risk in individualswith functional psychoses 96
Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis 96
Effect of acute tryptophan depletion on pre-frontal engagement 95
Progressive Voxel‐Wise Homotopic Connectivity from childhood to adulthood: Age‐related functional asymmetry in resting‐state functional magnetic resonance imaging 94
State-dependent reductions of local brain connectivity in schizophrenia and their relation to performance and symptoms: A functional magnetic resonance imaging study 94
Corrigendum: Perceived Family Functioning Profile in Adolescents at Clinical High Risk for Psychosis: Rigidity as a Possible Preventive Target 94
Franco Basaglia 1924-1980 94
Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis 94
Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation 94
An initial investigation of abnormal bodily phenomena in subjects at ultra high risk for psychosis: Their prevalence and clinical implications 94
Basic self-disturbances related to reduced anterior cingulate volume in subjects at ultra-high risk for psychosis 94
Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study 94
Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort 94
A transdiagnostic prodrome for severe mental disorders: an electronic health record study 93
Neurophysiological response to emotional faces with increasing intensity of fear: A skin conductance response study. 93
Prognosis of Brief Psychotic Episodes: A Meta-analysis 93
'Truman' signs and vulnerability to psychosis 93
Prognostic Accuracy of DSM-5 Attenuated Psychosis Symptoms in Adolescents: Prospective Real-World 5-Year Cohort Study 93
Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data 92
Love and brain: from mereological fallacy to folk neuroimaging 92
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: A multimodal imaging study 92
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction 92
Risk and protective factors for alcohol and tobacco related disorders: an umbrella review of observational studies 92
Modulation of neural response to happy and sad faces by acute tryptophan depletion 91
Imaging Genomics - An integrative approach to understand the biological susceptibility for schizophrenia 91
Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study 90
Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design 89
Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis 89
Roger Keith Syd Barrett (1946-2006) 88
Linking autism, regression and Landau-Kleffner syndrome: Integrative role of nerve growth factor 88
Differential diagnosis between the early onset of schizophrenia and bipolar disorder: Potential role of neuroimaging 88
Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis 88
Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care 88
Natural Language Processing markers in first episode psychosis and people at clinical high-risk 88
Totale 13.612
Categoria #
all - tutte 184.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021298 0 0 0 0 0 0 0 0 0 75 90 133
2021/20222.713 19 751 103 25 82 57 33 191 139 108 305 900
2022/20235.112 719 274 77 339 400 488 26 278 2.266 32 123 90
2023/20242.261 176 290 115 149 258 590 75 123 22 122 270 71
2024/20257.138 161 604 146 161 123 535 405 377 1.600 435 781 1.810
2025/202619.862 1.442 3.941 2.261 1.837 2.490 668 3.500 865 1.595 1.263 0 0
Totale 39.767